Accelerate Diagnostics Inc (AXDX) – Company Profile and SWOT Analysis

Accelerate Diagnostics Inc (AXDX) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company engaged in the development and commercialization of instruments for the identification and testing of antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, a platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit, which provides ID and AST results for patients with bacteremia or fungemia. It operates a manufacturing facility in Tucson, Arizona. The company sells products directly and also through a network of third-party distributors to hospital microbiology laboratories in foreign and domestic countries. Accelerate is headquartered in Tucson, Arizona, the US.

Scope

• Detailed information on Accelerate Diagnostics Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Accelerate Diagnostics Inc in the form of a SWOT analysis

• An in-depth view of the business model of Accelerate Diagnostics Inc including a breakdown and examination of key business segments

• News about Accelerate Diagnostics Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Accelerate Diagnostics Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Accelerate Diagnostics Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Accelerate Diagnostics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Danaher Corp

bioMerieux SA

Bruker Corp

Becton Dickinson and Co

T2 Biosystems Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Accelerate Diagnostics Inc - Key Facts

Accelerate Diagnostics Inc - Key Employees

Accelerate Diagnostics Inc - Key Employee Biographies

Accelerate Diagnostics Inc - Major Products and Services

Accelerate Diagnostics Inc - History

Accelerate Diagnostics Inc - Company Statement

Accelerate Diagnostics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Accelerate Diagnostics Inc - Business Description

Product Category: Products

Performance

Product Category: Services

Performance

Geographical Segment: Domestic

Performance

Geographical Segment: Foreign

Performance

R&D Overview

Accelerate Diagnostics Inc - SWOT Analysis

SWOT Analysis - Overview

Accelerate Diagnostics Inc - Strengths

Accelerate Diagnostics Inc - Weaknesses

Accelerate Diagnostics Inc - Opportunities

Accelerate Diagnostics Inc - Threats

Accelerate Diagnostics Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024

Accelerate Diagnostics Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024

Accelerate Diagnostics Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Oct 30, 2023: Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results

May 11, 2023: Accelerate Diagnostics reports first quarter 2023 financial results

Mar 15, 2023: Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results

Mar 14, 2023: Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement

Mar 08, 2023: Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Accelerate Diagnostics Inc, Key Facts

Accelerate Diagnostics Inc, Key Employees

Accelerate Diagnostics Inc, Key Employee Biographies

Accelerate Diagnostics Inc, Major Products and Services

Accelerate Diagnostics Inc, History

Accelerate Diagnostics Inc, Other Locations

Accelerate Diagnostics Inc, Subsidiaries

Accelerate Diagnostics Inc, Key Competitors

Accelerate Diagnostics Inc, Ratios based on current share price

Accelerate Diagnostics Inc, Annual Ratios

Accelerate Diagnostics Inc, Annual Ratios (Cont…1)

Accelerate Diagnostics Inc, Annual Ratios (Cont…2)

Accelerate Diagnostics Inc, Interim Ratios

Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024

Accelerate Diagnostics Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024

Accelerate Diagnostics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Accelerate Diagnostics Inc, Performance Chart (2019 – 2023)

Accelerate Diagnostics Inc, Ratio Charts

Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024

Accelerate Diagnostics Inc, Medical Equipment, Deals by Type, 2018 to YTD 2024

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports